Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) EPS (Weighted Average and Diluted): 2023-2024

Historic EPS (Weighted Average and Diluted) for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$11.89.

  • Zenas BioPharma's EPS (Weighted Average and Diluted) rose 75.70% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 121.64%. This contributed to the annual value of -$11.89 for FY2024, which is 50.97% up from last year.
  • According to the latest figures from FY2024, Zenas BioPharma's EPS (Weighted Average and Diluted) is -$11.89, which was up 50.97% from -$24.25 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's EPS (Weighted Average and Diluted) ranged from a high of -$11.89 in FY2024 and a low of -$24.25 during FY2023.
  • For the 2-year period, Zenas BioPharma's EPS (Weighted Average and Diluted) averaged around -$18.07, with its median value being -$18.07 (2023).
  • Data for Zenas BioPharma's EPS (Weighted Average and Diluted) shows a peak YoY surged of 50.97% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's EPS (Weighted Average and Diluted) (Yearly) stood at -$24.25 in 2023, then spiked by 50.97% to -$11.89 in 2024.